Skip to content

A study on whether a safe arm-cuff procedure can protect the brain and improve recovery after intracranial tumor removal.

Effects of Remote Ischemic Preconditioning on Neurologic Outcomes and Biochemical Markers in Patients Undergoing Intracranial Tumor Resection (RIP-TUMOR): A single-centre, prospective, randomised controlled trial - RIP-TUMOR

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099158
Enrollment
110
Registered
2025-12-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Remote ischemic preconditioning group: Remote ischemic preconditioning (RIPC) will be given by inflating an upper extremity blood-pressure cuff for 4 x 5 min to 20 mmHg above the systol

Sponsors

AIIMS Nagpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age more than or equal to 18 years 2. American society of anesthesiologists (ASA ) grade I or II 3. Patients with suspected primary (glioma) or metastatic brain tumor planned for elective craniotomy

Exclusion criteria

Exclusion criteria: 1. Known peripheral vascular disease 2. History of limb neuropathy, vascular surgery, deep vein thrombosis (DVT) 3. Any orthopaedic, surgical or soft tissue injury of upper limb 4. Pregnancy 5. Systolic blood pressure (SBP) more than 200 mmHg 6. Ankle brachial index less than 0.9

Design outcomes

Primary

MeasureTime frame
1. Serum biomarker levels - S100beta, NSE 2. Incidence of new cerebral ischemic lesions seen on MRITimepoint: 1. Serum biomarker levels - measured before the initiation of RIPC (baseline) and at 5th postoperative day 2. Incidence of new cerebral ischemic lesions seen on MRI- within 72 hours after surgery

Secondary

MeasureTime frame
Hospital length of stay & ICU length of stay mRS Mortality within 30 days of admission Safety and feasibility of RIPCTimepoint: Hospital length of stay & ICU length of stay- at discharge from hospital mRS recorded at the time of admission, discharge from hospital, 1 month and 6 months Mortality within 30 days of admission- at 30 days postoperative Safety and feasibility of RIPC- at discharge from hospital

Countries

India

Contacts

Public ContactDr Chayanika Kutum

AIIMS Nagpur

chayanikakutum@gmail.com9004598302

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026